SRTS - Sensus Healthcare Inc Stock Price, Fair Value and News

$6.82-0.14 (-2.01%)
Market Closed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

SRTS Price Action

Last 7 days

-1.5%


Last 30 days

-21.6%


Last 90 days

7.9%


Trailing 12 Months

137.6%

SRTS RSI Chart

AprMayJunJulAugSepOctNovDec2025102030405060708090

SRTS Valuation

Market Cap

111.8M

Price/Earnings (Trailing)

12.01

Price/Sales (Trailing)

2.71

EV/EBITDA

8.02

Price/Free Cashflow

53.46

SRTS Price/Sales (Trailing)

202220232024202524681012

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

SRTS Fundamentals

SRTS Revenue

Revenue (TTM)

41.3M

Rev. Growth (Yr)

212.33%

Rev. Growth (Qtr)

-15.15%

2016201820202022202410M20M30M40M

SRTS Earnings

Earnings (TTM)

9.3M

Earnings Growth (Yr)

183.74%

Earnings Growth (Qtr)

-24.63%

20162018202020222024-10M010M20M30M

SRTS Profitability

Operating Margin

72.81%

EBT Margin

31.16%

Return on Equity

17.2%

Return on Assets

15.56%

Free Cashflow Yield

1.87%

SRTS Investor Care

Shares Dilution (1Y)

0.05%

Diluted EPS (TTM)

0.57

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
2016201720182019202020212022202320245M10M15M20M25M30M35M40M45M
Net sales
YearQ1Q2Q3Q4
202431.7M36.4M41.3M0
202337.6M30.1M24.9M24.4M
202231.4M35.8M40.2M44.5M
202111.0M0027.0M
202023.5M17.2M13.0M9.6M
201925.9M27.3M26.8M27.3M
201822.2M23.3M24.8M26.4M
201716.1M17.5M19.0M20.6M
201611.4M12.5M13.7M14.8M
201500010.3M
Get all data in R, Python etc through our Historical Stock Data APIs
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and TransDermal Infusion system. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body, as well as distributes laser devices. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
 CEO
 WEBSITEsensushealthcare.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES42

Sensus Healthcare Inc Frequently Asked Questions


What is the ticker symbol for Sensus Healthcare Inc? What does SRTS stand for in stocks?

SRTS is the stock ticker symbol of Sensus Healthcare Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Sensus Healthcare Inc (SRTS)?

As of Wed Jan 08 2025, market cap of Sensus Healthcare Inc is 111.78 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SRTS stock?

You can check SRTS's fair value in chart for subscribers.

Is Sensus Healthcare Inc a good stock to buy?

The fair value guage provides a quick view whether SRTS is over valued or under valued. Whether Sensus Healthcare Inc is cheap or expensive depends on the assumptions which impact Sensus Healthcare Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SRTS.

What is Sensus Healthcare Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Jan 08 2025, SRTS's PE ratio (Price to Earnings) is 12.01 and Price to Sales (PS) ratio is 2.71. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SRTS PE ratio will change depending on the future growth rate expectations of investors.